ZA200500768B - Crystal forms os quinoxaline-2-carboxylic acid Ä4-carbomoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-,ethyl-octylÜ-amide - Google Patents
Crystal forms os quinoxaline-2-carboxylic acid Ä4-carbomoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-,ethyl-octylÜ-amideInfo
- Publication number
- ZA200500768B ZA200500768B ZA200500768A ZA200500768A ZA200500768B ZA 200500768 B ZA200500768 B ZA 200500768B ZA 200500768 A ZA200500768 A ZA 200500768A ZA 200500768 A ZA200500768 A ZA 200500768A ZA 200500768 B ZA200500768 B ZA 200500768B
- Authority
- ZA
- South Africa
- Prior art keywords
- octylü
- carbomoyl
- fluorobenzyl
- quinoxaline
- dihydroxy
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title 1
- UPUZGXILYFKSGE-UHFFFAOYSA-N quinoxaline-2-carboxylic acid Chemical compound C1=CC=CC2=NC(C(=O)O)=CN=C21 UPUZGXILYFKSGE-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40321602P | 2002-08-12 | 2002-08-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200500768B true ZA200500768B (en) | 2006-07-26 |
Family
ID=31715961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200500768A ZA200500768B (en) | 2002-08-12 | 2005-01-26 | Crystal forms os quinoxaline-2-carboxylic acid Ä4-carbomoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-,ethyl-octylÜ-amide |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20040072834A1 (pt) |
| EP (1) | EP1539715A1 (pt) |
| JP (1) | JP2005538130A (pt) |
| AP (1) | AP2005003226A0 (pt) |
| AR (1) | AR040839A1 (pt) |
| AU (1) | AU2003250450A1 (pt) |
| BR (1) | BR0313378A (pt) |
| CA (1) | CA2494776A1 (pt) |
| EC (1) | ECSP055588A (pt) |
| GT (1) | GT200300169A (pt) |
| IL (1) | IL166548A0 (pt) |
| IS (1) | IS7674A (pt) |
| MX (1) | MXPA05001781A (pt) |
| NO (1) | NO20050540L (pt) |
| OA (1) | OA12894A (pt) |
| PA (1) | PA8580401A1 (pt) |
| PE (1) | PE20040866A1 (pt) |
| TN (1) | TNSN05035A1 (pt) |
| TW (1) | TW200407316A (pt) |
| UY (1) | UY27928A1 (pt) |
| WO (1) | WO2004014875A1 (pt) |
| ZA (1) | ZA200500768B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201130810A (en) | 2009-12-23 | 2011-09-16 | Ironwood Pharmaceuticals Inc | CRTH2 modulators |
| US20130259830A1 (en) | 2010-07-12 | 2013-10-03 | Ironwood Pharmaceuticals, Inc. | Crth2 modulators |
| US20130216552A1 (en) | 2010-07-12 | 2013-08-22 | Ironwood Pharmaceuticals, Inc. | Crth2 modulators |
| CN102276539B (zh) * | 2011-06-29 | 2013-08-14 | 赵雪梅 | 一种具有抑菌作用的化合物及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE640616A (pt) * | 1962-12-19 | |||
| US3492397A (en) * | 1967-04-07 | 1970-01-27 | Warner Lambert Pharmaceutical | Sustained release dosage in the pellet form and process thereof |
| US4060598A (en) * | 1967-06-28 | 1977-11-29 | Boehringer Mannheim G.M.B.H. | Tablets coated with aqueous resin dispersions |
| US3538214A (en) * | 1969-04-22 | 1970-11-03 | Merck & Co Inc | Controlled release medicinal tablets |
| US4173626A (en) * | 1978-12-11 | 1979-11-06 | Merck & Co., Inc. | Sustained release indomethacin |
| CN1248968A (zh) * | 1997-02-26 | 2000-03-29 | 辉瑞大药厂 | 杂芳基－己酸酰胺衍生物、其制备方法及其作为MIP－1α与其CCRI受体结合的选择性抑制剂的用途 |
| KR100385529B1 (ko) * | 1998-02-05 | 2003-05-27 | 화이자 프로덕츠 인코포레이티드 | 신규 디하이드록시헥산산 유도체 |
-
2003
- 2003-07-31 MX MXPA05001781A patent/MXPA05001781A/es not_active Application Discontinuation
- 2003-07-31 WO PCT/IB2003/003464 patent/WO2004014875A1/en not_active Application Discontinuation
- 2003-07-31 AP AP2005003226A patent/AP2005003226A0/xx unknown
- 2003-07-31 EP EP03784383A patent/EP1539715A1/en not_active Withdrawn
- 2003-07-31 JP JP2004527195A patent/JP2005538130A/ja active Pending
- 2003-07-31 OA OA1200500028A patent/OA12894A/en unknown
- 2003-07-31 BR BR0313378-8A patent/BR0313378A/pt not_active Application Discontinuation
- 2003-07-31 CA CA002494776A patent/CA2494776A1/en not_active Abandoned
- 2003-07-31 AU AU2003250450A patent/AU2003250450A1/en not_active Abandoned
- 2003-08-05 UY UY27928A patent/UY27928A1/es not_active Application Discontinuation
- 2003-08-06 GT GT200300169A patent/GT200300169A/es unknown
- 2003-08-06 TW TW092121503A patent/TW200407316A/zh unknown
- 2003-08-08 AR AR20030102881A patent/AR040839A1/es unknown
- 2003-08-08 PE PE2003000794A patent/PE20040866A1/es not_active Application Discontinuation
- 2003-08-08 US US10/637,475 patent/US20040072834A1/en not_active Abandoned
- 2003-08-12 PA PA20038580401A patent/PA8580401A1/es unknown
-
2005
- 2005-01-26 ZA ZA200500768A patent/ZA200500768B/xx unknown
- 2005-01-27 IS IS7674A patent/IS7674A/is unknown
- 2005-01-27 IL IL16654805A patent/IL166548A0/xx unknown
- 2005-01-31 NO NO20050540A patent/NO20050540L/no unknown
- 2005-02-03 EC EC2005005588A patent/ECSP055588A/es unknown
- 2005-02-11 TN TNP2005000035A patent/TNSN05035A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20040072834A1 (en) | 2004-04-15 |
| AP2005003226A0 (en) | 2005-03-31 |
| AR040839A1 (es) | 2005-04-20 |
| MXPA05001781A (es) | 2005-04-25 |
| PA8580401A1 (es) | 2004-02-16 |
| IL166548A0 (en) | 2006-01-15 |
| UY27928A1 (es) | 2004-03-31 |
| OA12894A (en) | 2006-10-13 |
| NO20050540L (no) | 2005-03-10 |
| AU2003250450A1 (en) | 2004-02-25 |
| WO2004014875A1 (en) | 2004-02-19 |
| TW200407316A (en) | 2004-05-16 |
| CA2494776A1 (en) | 2004-02-19 |
| JP2005538130A (ja) | 2005-12-15 |
| PE20040866A1 (es) | 2004-11-26 |
| IS7674A (is) | 2005-01-27 |
| ECSP055588A (es) | 2005-04-18 |
| TNSN05035A1 (fr) | 2007-05-14 |
| BR0313378A (pt) | 2005-07-12 |
| EP1539715A1 (en) | 2005-06-15 |
| GT200300169A (es) | 2004-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003241561A1 (en) | Pyrazolo-pyrimidine aniline compounds | |
| IS7755A (is) | Aðferð við framleiðslu á (S,S)-cis-2-benshýdríl-3-bensýlamínókínuklídín | |
| IL164597A0 (en) | Substituted 3-amino-thienoÄ2,3-bÜpyridine-2-carboxylic acid amide compounds and processes for preparing and their uses | |
| ZA200409989B (en) | Novel substituted sulfamate anticonvulsant derivatives. | |
| AU2003282548A1 (en) | Nano-chem-fet based biosensors | |
| HK1072772A1 (en) | Polymorph of acid 4-Ä2-Ä4-Ä1-(2-ethoxyethyl)-1H-benzimidazole-2-ilÜ-1-piperidinylÜethylÜ-alpha, alpha-dimethyl-benzeneacetic-4-Ä2-Ä4-Ä1-(2- | |
| ZA200300208B (en) | Manufacture of high octane alkylate. | |
| ZA200501624B (en) | Flat lamp, production method thereof and application of same. | |
| AU2003251779A1 (en) | Electrode connector with rivet | |
| ZA200500768B (en) | Crystal forms os quinoxaline-2-carboxylic acid Ä4-carbomoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-,ethyl-octylÜ-amide | |
| AU2003212979A1 (en) | Substituted fused pyrazolecarboxylic acid arylamides and related compounds | |
| AU2003225474A1 (en) | Facilitating improved workflow | |
| ITMI20022704A1 (it) | Procedimento per la produzione di mesitilene e durene. | |
| AU2003276026A1 (en) | Bicalutamide forms | |
| NO20023357D0 (no) | Blanding | |
| DE60324703D1 (de) | Barbitursäure derivaten. | |
| IL163572A0 (en) | Method for manufacturing flat paneldisplay substrates orbotech ltd. | |
| AU2003255454A1 (en) | Heterocyclylcarbonyl aminocyclopropane carboxylic acid derivatives | |
| AU2002950815A0 (en) | Recovery nickel | |
| AU2003252008A1 (en) | High performance ortho upr | |
| GB0212068D0 (en) | SIM Configuration | |
| AU2003301750A1 (en) | Recovery process | |
| AU2003272083A1 (en) | Salt of 6-(1, 3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid with n, n-dimethyl-imidodicarbonimidic diamide | |
| EP1587833A4 (en) | EPAD, AN OOCYTE SPECIFIC PROTEIN | |
| AU2003298131A1 (en) | Sim card with memorization of the home network identification |